GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » HH Biotechnology Holdings Co (OTCPK:HHBT) » Definitions » EV-to-FCF

HHBT (HH Biotechnology Holdings Co) EV-to-FCF : 0.00 (As of Sep. 25, 2024)


View and export this data going back to . Start your Free Trial

What is HH Biotechnology Holdings Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, HH Biotechnology Holdings Co's Enterprise Value is $0.00 Mil. HH Biotechnology Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2016 was $4.82 Mil. Therefore, HH Biotechnology Holdings Co's EV-to-FCF for today is 0.00.

The historical rank and industry rank for HH Biotechnology Holdings Co's EV-to-FCF or its related term are showing as below:

HHBT's EV-to-FCF is not ranked *
in the Real Estate industry.
Industry Median: 17.19
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-25), HH Biotechnology Holdings Co's stock price is $0.0001. HH Biotechnology Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2016 was $0.190. Therefore, HH Biotechnology Holdings Co's PE Ratio for today is 0.00.


HH Biotechnology Holdings Co EV-to-FCF Historical Data

The historical data trend for HH Biotechnology Holdings Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HH Biotechnology Holdings Co EV-to-FCF Chart

HH Biotechnology Holdings Co Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.59 22.53 8.96 9.83 11.51

HH Biotechnology Holdings Co Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HH Biotechnology Holdings Co's EV-to-FCF

For the Real Estate Services subindustry, HH Biotechnology Holdings Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HH Biotechnology Holdings Co's EV-to-FCF Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, HH Biotechnology Holdings Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where HH Biotechnology Holdings Co's EV-to-FCF falls into.



HH Biotechnology Holdings Co EV-to-FCF Calculation

HH Biotechnology Holdings Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.001/4.82
=0.00

HH Biotechnology Holdings Co's current Enterprise Value is $0.00 Mil.
HH Biotechnology Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HH Biotechnology Holdings Co  (OTCPK:HHBT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

HH Biotechnology Holdings Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/0.190
=0.00

HH Biotechnology Holdings Co's share price for today is $0.0001.
HH Biotechnology Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.190.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


HH Biotechnology Holdings Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of HH Biotechnology Holdings Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


HH Biotechnology Holdings Co Business Description

Traded in Other Exchanges
N/A
Address
No. 69 Heping North Street, C-Site, 25th - 26th Floor, Presidential Building, Heping District, Shenyang, CHN, 110003
HH Biotechnology Holdings Co is engaged in developing, producing and marketing of healthy food, supplements, medicine, and cosmetics.
Executives
Yizhao Zhang director 45 OLD MILLSTONE DRIVE, NIT 6, EAST WINDSOR NJ 08520

HH Biotechnology Holdings Co Headlines

No Headlines